Precigen, Inc. Accrued Expenses

Accrued Expenses of PGEN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Accrued Expenses growth rates and interactive chart. Accrued expense is expense which has been incurred but not yet paid. Expense must be recorded in the accounting period in which it is incurred. Therefore, accrued expense must be recognized in the accounting period in which it occurs rather than in the following period in which it will be paid.

Highlights and Quick Summary

  • Accrued Expenses for the quarter ending March 31, 2023 was $4.96 Million (a -22.24% decrease compared to previous quarter)
  • Year-over-year quarterly Accrued Expenses increased by 1.95%
  • Annual Accrued Expenses for 2022 was $6.38 Million (a -18.83% decrease from previous year)
  • Annual Accrued Expenses for 2021 was $7.86 Million (a -2.98% decrease from previous year)
  • Annual Accrued Expenses for 2020 was $8.1 Million (a -38.65% decrease from previous year)
Visit stockrow.com/PGEN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Accrued Expenses of Precigen, Inc.

Most recent Accrued Expensesof PGEN including historical data for past 10 years.

Interactive Chart of Accrued Expenses of Precigen, Inc.

Precigen, Inc. Accrued Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $4.96 – – – –
2022 $6.38 $5.79 $4.86 $6.05 $6.38
2021 $7.86 $8.08 $7.77 $6.43 $7.86
2020 $8.1 $7.57 $7.72 $7.21 $8.1
2019 $13.2 $9.86 $9.03 $7.78 $13.2
2018 $9.96 $23.89 $14.02 $11.36 $9.96
2017 $6.47 $11.21 $9.1 $7.48 $6.47
2016 $6.54 $11.01 $9.47 $8.28 $6.54
2015 $19.05 $14.48 $12.43 $8.03 $19.05
2014 $7.74 $6.7 $4.09 $2.76 $7.74
2013 – $5.16 $3.69 $3.32 $5.16
2012 – – – – $3.77

Business Profile of Precigen, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com